| HER2 expression, copy number variation and survival outcomes in HER2-low non-metastatic breast cancer: an international multicentre cohort study and TCGA-METABRIC analysis RSYC Tan, WS Ong, KH Lee, AH Lim, S Park, YH Park, CH Lin, YS Lu, ... BMC medicine 20 (1), 105, 2022 | 76 | 2022 |
| Continued response to one dose of nivolumab complicated by myasthenic crisis and myositis RYC Tan, CK Toh, A Takano Journal of Thoracic Oncology 12 (7), e90-e91, 2017 | 38 | 2017 |
| Hereditary diffuse gastric cancer: What the clinician should know RYC Tan, J Ngeow World journal of gastrointestinal oncology 7 (9), 153, 2015 | 34 | 2015 |
| Using quality improvement methods and time-driven activity-based costing to improve value-based cancer care delivery at a cancer genetics clinic RYC Tan, M Met-Domestici, K Zhou, AB Guzman, ST Lim, KC Soo, ... Journal of oncology practice 12 (3), e320-e331, 2016 | 31 | 2016 |
| Multi-center evaluation of artificial intelligent imaging and clinical models for predicting neoadjuvant chemotherapy response in breast cancer TH Qi, OH Hian, AM Kumaran, TJ Tan, TRY Cong, GL Su-Xin, EH Lim, ... Breast Cancer Research and Treatment 193 (1), 121-138, 2022 | 15 | 2022 |
| HER2 positive rates are enriched amongst colorectal cancer brain metastases: a study amongst 1920 consecutive patients RYC Tan, MD Camat, M Ng, TH Lim, AST Lim, KH Lim, IBH Tan Annals of Oncology 29 (7), 1598-1599, 2018 | 14 | 2018 |
| COVID-19 Severity and Waning Immunity After up to 4 mRNA Vaccine Doses in 73 608 Patients With Cancer and 621 475 Matched Controls in Singapore: A Nationwide Cohort Study WC Tan, JYJ Tan, JSJ Lim, RYC Tan, ARYB Lee, FL Leong, SC Lee, ... JAMA oncology 9 (9), 1221-1229, 2023 | 12 | 2023 |
| Understanding patients' views and willingness toward the use of telehealth in a cancer genetics service in Asia J Sim, T Shaw, ST Li, E Courtney, J Yuen, J Chiang, M Nazir, R Tan, ... Journal of genetic counseling 30 (6), 1658-1670, 2021 | 12 | 2021 |
| Inferring cancer disease response from radiology reports using large language models with data augmentation and prompting RSYC Tan, Q Lin, GH Low, R Lin, TC Goh, CCE Chang, FF Lee, WY Chan, ... Journal of the American Medical Informatics Association 30 (10), 1657-1664, 2023 | 9 | 2023 |
| Using the technology acceptance model to examine acceptance of telemedicine by cancer patients in an ambulatory care setting ZY Chan, CF Lim, JL Leow, FY Chium, SW Lim, CHM Tong, JJX Zhou, ... Proceedings of Singapore Healthcare 31, 20101058221104578, 2022 | 7 | 2022 |
| Identifying ataxia‐telangiectasia in cancer patients: Novel insights from an interesting case and review of literature J Cao, RYC Tan, ST Li, E Courtney, RCH Goh, BE Fan, K Sommat, ... Clinical Case Reports 9 (2), 995-1009, 2021 | 7 | 2021 |
| Efficacy, patterns of use and cost of pertuzumab in the treatment of HER2+ metastatic breast cancer in Singapore: the National Cancer Centre Singapore experience S Rahardja, RYC Tan, R Sultana, FL Leong, EH Lim World Journal of Clinical Oncology 11 (3), 143, 2020 | 6 | 2020 |
| Use of telephone intake for family history taking at a cancer genetics service in Asia XW Chin, ZLT Ang, RYC Tan, E Courtney, T Shaw, Y Chen, ST Li, ... Journal of Genetic Counseling 29 (6), 1192-1199, 2020 | 4 | 2020 |
| Human epidermal growth factor receptor 2 positive rates in invasive lobular breast carcinoma: the Singapore experience GJ Kee, RYC Tan, S Rehena, JJX Lee, MWW Zaw, WX Lian, J Yeong, ... World Journal of Clinical Oncology 11 (5), 283, 2020 | 2 | 2020 |
| Value-Based Healthcare in Residency Training: a Perspective from Singapore RYC Tan, GSE Tan Medical Science Educator 27, 423-426, 2017 | 2 | 2017 |
| Automated classification of disease response in radiology reports using natural language processing. HX Ong, Y Cai, ZM Yi, WH Tee, RS Tan Ying Cong, WC Tan, A Bakr Azam JCO Global Oncology 9 (Supplement_1), 108-108, 2023 | 1 | 2023 |
| Retrieval-augmented large language models for clinical trial screening. R Tan, SX Ho, SVF Oo, SL Chua, MWW Zaw, DSW Tan Journal of Clinical Oncology 42 (16_suppl), e13611-e13611, 2024 | | 2024 |
| Outcomes in Nonmetastatic Hormone Receptor–Positive HER2-Negative Pure Mucinous Breast Cancer: A Multicenter Cohort Study RYC Tan, WS Ong, KH Lee, S Park, J Iqbal, YH Park, JE Lee, JH Yu, ... Journal of the National Comprehensive Cancer Network 22 (2D), 2024 | | 2024 |
| Abstract PO4-07-03: Machine learning breast cancer risk prediction using sequential past mammograms-a pilot study L Leong, M Xu, W Huang, E Zhang, E Loh, SY Teo, GH Lim, VKM Tan, ... Cancer Research 84 (9_Supplement), PO4-07-03-PO4-07-03, 2024 | | 2024 |
| Use of Natural Language Processing to Infer Sites of Metastatic Disease From Radiology Reports at Scale SB Tay, GH Low, GJE Wong, HJ Tey, FL Leong, C Li, MLK Chua, ... JCO Clinical Cancer Informatics 8, e2300122, 2024 | | 2024 |
